NHI 2
- Product Name
- NHI 2
- CAS No.
- 1269802-97-2
- Chemical Name
- NHI 2
- Synonyms
- NHI 2;NHI-2 >=98% (HPLC);Methyl 1-hydroxy-6-phenyl-4-(trifluoromethyl)-1H-indole-2-carboxylate;1H-Indole-2-carboxylic acid, 1-hydroxy-6-phenyl-4-(trifluoromethyl)-, methyl ester
- CBNumber
- CB73146340
- Molecular Formula
- C17H12F3NO3
- Formula Weight
- 335.28
- MOL File
- 1269802-97-2.mol
NHI 2 Property
- Boiling point:
- 495.7±55.0 °C(Predicted)
- Density
- 1.36±0.1 g/cm3(Predicted)
- storage temp.
- -20°
- solubility
- Soluble in DMSO (up to 25 mg/ml).
- form
- solid
- pka
- 10+-.0.58(Predicted)
- color
- Off-white
- Stability:
- Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 1 month.
- InChI
- 1S/C17H12F3NO3/c1-24-16(22)15-9-12-13(17(18,19)20)7-11(8-14(12)21(15)23)10-5-3-2-4-6-10/h2-9,23H,1H3
- InChIKey
- YPPFWRWCZNXINO-UHFFFAOYSA-N
- SMILES
- ON(C(C(OC)=O)=C1)C2=C1C(C(F)(F)F)=CC(C3=CC=CC=C3)=C2
Safety
- WGK Germany
- WGK 3
- Storage Class
- 11 - Combustible Solids
N-Bromosuccinimide Price
- Product number
- SML1463
- Product name
- NHI-2
- Purity
- ≥98% (HPLC)
- Packaging
- 5 mg
- Price
- $134
- Updated
- 2025/07/31
- Product number
- SML1463
- Product name
- NHI-2
- Purity
- ≥98% (HPLC)
- Packaging
- 25 mg
- Price
- $535
- Updated
- 2025/07/31
- Product number
- 30201
- Product name
- NHI 2
- Packaging
- 1mg
- Price
- $32
- Updated
- 2024/03/01
- Product number
- 30201
- Product name
- NHI 2
- Packaging
- 5mg
- Price
- $93
- Updated
- 2024/03/01
- Product number
- 30201
- Product name
- NHI 2
- Packaging
- 10mg
- Price
- $122
- Updated
- 2024/03/01
NHI 2 Chemical Properties,Usage,Production
Description
NHI 2 is an inhibitor of lactate dehydrogenase A (LDHA; IC50 = 14.7 μM). It is selective for LDHA over LDHB (IC50 = 55.8 μM). It inhibits lactate production in HeLa cells when used at concentrations of 100 and 200 μM. NHI 2 is cytotoxic to HeLa cells (IC50 = 33.4 μM).
Uses
NHI-2 is a lactate dehydrogenase A (LDHA) inhibitor with an IC50 of 14.7 μM. NHI-2 shows selective for LDHA over LDHB (IC50 = 55.8 μM). NHI-2 is an efficient anti-glycolytic agent. NHI-2 enhances apoptosis, induces cell cycle arrest at S/G2 phases. NHI-2 has a broad spectrum anti-proliferative activity in cancer cells. NHI-2 affects extracellular acidification rate and ATP production. NHI-2 suppress tumor growth in mice[1][2].
in vivo
NHI-2 (0.9 mg/kg; Intra-tumoral; once daily for 15 days) can suppress tumor volume when combined with immune checkpoint inhibitors (ICIs) in murine B78 melanoma tumor model[2].
| Animal Model: | C57BL/6 female mice (6-8 weeks) were intradermally implanted with B78 syngeneic melanoma cells[2] |
| Dosage: | 0.9 mg/kg |
| Administration: | Intra-tumoral (IT) via percutaneous needle puncture; once daily for 15 days |
| Result: | Suppressed tumor volume when combined with checkpoint inhibitors (ICIs). |
storage
Store at +4°C
References
[1] GRANCHI C, CALVARESI E C, TUCCINARDI T, et al. Assessing the differential action on cancer cells of LDH-A inhibitors based on the N-hydroxyindole-2-carboxylate (NHI) and malonic (Mal) scaffolds†[J]. Organic & Biomolecular Chemistry, 2013, 38: 6588-6596. DOI:10.1039/c3ob40870a
[2] M MAFTOUH. Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia[J]. British Journal of Cancer, 2013, 110 1: 172-182. DOI:10.1038/bjc.2013.681
[3] CARLOTTA GRANCHI. Discovery of N-Hydroxyindole-Based Inhibitors of Human Lactate Dehydrogenase Isoform A (LDH-A) as Starvation Agents against Cancer Cells[J]. Journal of Medicinal Chemistry, 2011, 54 6: 1599-1612. DOI:10.1021/jm101007q
[4] S J ALLISON. Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathways[J]. Oncogenesis, 2014, 3 5: e102-e102. DOI:10.1038/oncsis.2014.16
[5] MICHAEL A LEA Charles D Yolanda Guzman. Inhibition of Growth by Combined Treatment with Inhibitors of Lactate Dehydrogenase and either Phenformin or Inhibitors of 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase 3.[J]. Anticancer research, 2016, 36 4: 1479-1488.
NHI 2 Preparation Products And Raw materials
Raw materials
Preparation Products
NHI 2 Suppliers
- Tel
- 020-39119399 18927568969
- Fax
- 020-39119999
- isunpharm@qq.com
- Country
- China
- ProdList
- 4720
- Advantage
- 55
- Tel
- 021-11111111 11111111111
- Fax
- qq:546919421
- 546919421@qq.com
- Country
- China
- ProdList
- 3601
- Advantage
- 55
- Tel
- 021-65675885 18964387627
- Fax
- 021-65675885
- info@efebio.com
- Country
- China
- ProdList
- 9803
- Advantage
- 58
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60
- Tel
- 400-9205774
- sales@glpbio.cn
- Country
- China
- ProdList
- 6777
- Advantage
- 58
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32470
- Advantage
- 58
- Tel
- +1-708-310-1919 +1-13798911105
- Fax
- 708-557-7486
- sales@invivochem.cn
- Country
- United States
- ProdList
- 6391
- Advantage
- 58
- Tel
- 18818260767
- Fax
- QQ 3610331285
- sales@chemegen.com
- Country
- China
- ProdList
- 11218
- Advantage
- 58
- Tel
- 021-58432009 400-005-6266
- Fax
- 021-58436166
- marketing1@energy-chemical.com
- Country
- China
- ProdList
- 44894
- Advantage
- 58
- Tel
- 15865264761
- 486064515@qq.com
- Country
- China
- ProdList
- 4858
- Advantage
- 58